Younes-Ibrahim M, Burth P, Faria M V, Buffin-Meyer B, Marsy S, Barlet-Bas C, Cheval L, Doucet A
Laboratoire de physiologie cellulaire, Collège de France, Paris.
C R Acad Sci III. 1995 May;318(5):619-25.
Clinical manifestations of leptospirosis include disorders of the electrolytical balance which might be related to inhibition of Na,K-ATPase. Although the physiopathological cellular mechanism of leptospirosis remains unknown, a bacterial endotoxin has been incriminated. Therefore, we evaluated whether a glycolipoprotein fraction extracted from Leptospira interrogans and known to be cytotoxic might inhibit Na,K-ATPase. This glycolipoprotein fraction (GLP) inhibited Na,K-ATPase activity in rabbit kidney epithelial cells as well as Na,K-ATPase purified from rabbit kidney medulla. Inhibition was dose-dependent, and at maximum it almost abolished Na,K-ATPase activity whereas it had no effect on other enzymes. The GLP did not change the apparent affinity of Na,K-ATPase for potassium whereas it increased that for sodium, revealing a mechanism of inhibition different from that of ouabain. Finally, the inhibitory principle present in the GLP preparation was thermostable and was curtailed by the presence of albumin. In conclusion, a glycolipoproteic fraction extracted from Leptospira interrogans contains a specific inhibitor of Na,K-ATPase. This glycolipoproteic fraction which is present in diseased tissues might induce, through this inhibitor, cellular dysfunctions responsible for the symptoms, in particular those associated with electrolytical disorders such as disturbances of renal electrolyte handling, cardiac arrhythmia or diarrhoea.
钩端螺旋体病的临床表现包括电解质平衡紊乱,这可能与钠钾 -ATP 酶的抑制有关。尽管钩端螺旋体病的生理病理细胞机制尚不清楚,但细菌内毒素被认为与此有关。因此,我们评估了从问号钩端螺旋体中提取的已知具有细胞毒性的糖脂蛋白组分是否会抑制钠钾 -ATP 酶。该糖脂蛋白组分(GLP)抑制兔肾上皮细胞中的钠钾 -ATP 酶活性以及从兔肾髓质纯化的钠钾 -ATP 酶。抑制作用呈剂量依赖性,最大时几乎完全消除钠钾 -ATP 酶活性,而对其他酶无影响。GLP 并未改变钠钾 -ATP 酶对钾的表观亲和力,而增加了其对钠的表观亲和力,揭示了一种不同于哇巴因的抑制机制。最后,GLP 制剂中的抑制成分具有热稳定性,并且会因白蛋白的存在而减少。总之,从问号钩端螺旋体中提取的糖脂蛋白组分含有钠钾 -ATP 酶的特异性抑制剂。存在于患病组织中的这种糖脂蛋白组分可能通过这种抑制剂诱导导致症状的细胞功能障碍,特别是那些与电解质紊乱相关的症状,如肾脏电解质处理紊乱、心律失常或腹泻。